Key result
Functional asplenia (HJB+) after splenectomy was associated with a shorter median time to first thrombotic event and more cumulative thrombotic events compared to HJB-.
Why the study?
Does functional asplenia after splenectomy increase the risk of thrombotic cardiovascular events?
Case-Control (n=298)
Does functional asplenia after splenectomy increase the risk of thrombotic cardiovascular events?
Functional asplenia after splenectomy is associated with sustained inflammation, increased platelet activation, and a significantly higher risk of thrombotic cardiovascular events.
Answers are grounded in this paper and cite their sources.
May heighten post-splenectomy thrombotic risk in functional asplenia; hypothesis-generating and requires prospective confirmation.
Purpose: Patients after splenectomy are prone to complicated thrombosis, atherosclerosis and chronic thromboembolic pulmonary hypertension (CTEPH). We tested the hypothesis that sustained inflammation and abnormal platelet function in splenectomized patients may contribute to the pathogenesis. Methods: In this prospective case control study, we evaluated 298 outpatients after splenectomy. 177 (89.4%) splenectomies were due to trauma. Functional asplenia was assessed by the presence of Howell-Jolly bodies (HJB) on Wright-blood smears. Platelet function was tested in a subset of 36 splenectomized patients and in 7 matched controls. Results: Despite similar age, functionally asplenic patients (HJB+) were more likely to have diabetes mellitus (26.1%) and stable ischemic heart disease (26.1%) compared to HJB- patients (10.5%, p=0.048; 5.3%, p=0.022) and controls (3.7%, p=0.037; 0%, p=0.047). 7 splenectomized patients were diagnosed with CTEPH, all of whom were HJB+. HJB+ patients had a significantly higher number of cumulative thrombotic events (n=70) compared to HJB- patients (n=11, p=0.001) and controls (n=2, p<0.001). Time to first thrombotic event was shorter in HJB+ patients (median [25th-75th percentiles]: 316 [165–514] months) compared to HJB- patients (478 [466–483] months; p=0.01) and controls (542 [502–581] months; p=0.003). T cells, NK cells and B cells were significantly higher in HJB+ than in HJB- patients and controls (Table 2). Multiplate and flow cytometry analyses revealed increased platelet activatability in HJB+ compared to HJB- patients and controls (Table 2).
No takes yet. Share an insight, caveat, or question.
Gerges et al. (2017) conducted a case-control in Splenectomy (n=298). Functional asplenia (Howell-Jolly bodies positive) vs. Howell-Jolly bodies negative patients and matched controls was evaluated on Time to first thrombotic event (p=0.01). Functional asplenia (HJB+) after splenectomy was associated with a shorter median time to first thrombotic event and more cumulative thrombotic events compared to HJB-.
Synapse has enriched 10 related papers. Consider them for comparative context: